Scarica l'app Stockscreener
1.61
3.59%
-0.06
Dopo l'orario di chiusura:
1.63
0.02
+1.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.67
Aprire:
$1.72
Volume 24 ore:
6.79M
Relative Volume:
1.56
Capitalizzazione di mercato:
$470.61M
Reddito:
-
Utile/perdita netta:
$-63.08M
Rapporto P/E:
-5.963
EPS:
-0.27
Flusso di cassa netto:
$-72.53M
1 W Prestazione:
-12.02%
1M Prestazione:
+37.61%
6M Prestazione:
+146.48%
1 anno Prestazione:
+71.44%
Intervallo 1D:
$1.59
$1.83
Intervallo di 1 settimana:
$1.51
$1.84
Portata 52W:
$0.515
$1.90
Ocugen Inc Stock (OCGN) Company Profile
Nome
Ocugen Inc
Settore
Industria
Telefono
484-328-4701
Indirizzo
11 GREAT VALLEY PARKWAY, MALVERN, PA
Confronta OCGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.61 | 509.06M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-15 | Iniziato | Maxim Group | Buy |
| 2023-03-01 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | Iniziato | Mizuho | Buy |
| 2022-06-15 | Ripresa | ROTH Capital | Buy |
| 2022-06-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-07-26 | Iniziato | Noble Capital Markets | Outperform |
| 2021-06-11 | Downgrade | ROTH Capital | Buy → Neutral |
| 2021-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
Mostra tutto
Ocugen Inc Borsa (OCGN) Ultime notizie
How Ocugen Inc. stock reacts to job market dataWeekly Risk Report & Community Consensus Picks - newser.com
Will earnings trigger a reversal in Ocugen Inc.Portfolio Performance Report & Entry Point Confirmation Signals - newser.com
Ocugen Inc Stock Analysis and ForecastREITs Market Trends & Smart Trading Plans for Every Investor Type - earlytimes.in
Best data tools to analyze Ocugen Inc. stock2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
Signal strength of Ocugen Inc. stock in tech scannersCPI Data & Proven Capital Preservation Methods - newser.com
A activityEarnings Overview Report & Precise Buy Zone Tips - newser.com
Will Ocugen Inc. stock maintain dividend yieldJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com
Can Ocugen Inc. (2H51) stock sustain double digit ROE2025 Volume Leaders & Fast Gain Swing Trade Alerts - newser.com
Ocugen Inc. stock prediction for this weekTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com
Combining price and volume data for Ocugen Inc.Long Setup & Free Growth Oriented Trading Recommendations - newser.com
Ocugen Stock Shock: What’s Next? - StocksToTrade
Tools to assess Ocugen Inc.’s risk profileMarket Volume Report & Safe Entry Point Alerts - newser.com
Ocugen (NASDAQ:OCGN) Shares Down 7.4%Should You Sell? - MarketBeat
Ocugen Inc. Stock Falls Friday, Underperforms Market - 富途牛牛
Will Ocugen Inc. stock outperform international peers2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Exit strategy if you’re trapped in Ocugen Inc.July 2025 Snapshot & AI Enhanced Market Trend Forecasts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Ocugen (NASDAQ:OCGN) - MarketBeat
What data driven models say about Ocugen Inc.’s futureWeekly Trading Summary & Community Verified Trade Signals - newser.com
How Ocugen Inc. (2H51) stock moves on employment data2025 Bull vs Bear & Daily Growth Stock Investment Tips - newser.com
Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss - MSN
Ocugen, Inc. Hits New 52-Week High of $1.90, Marking Major Milestone - Markets Mojo
Ocugen to Highlight Gene Therapy Pipeline at Key Industry and Investor Conferences - MyChesCo
Published on: 2025-10-06 02:02:01 - newser.com
Automated trading signals detected on Ocugen Inc.Market Rally & Weekly Breakout Opportunity Watchlist - newser.com
Analyzing recovery setups for Ocugen Inc. investorsJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Real time pattern detection on Ocugen Inc. stockFed Meeting & Smart Money Movement Alerts - newser.com
Published on: 2025-10-05 03:08:53 - newser.com
What drives Ocugen Inc 2H51 stock priceBull Market Opportunities & Explosive Growth Opportunities - earlytimes.in
Is Ocugen Inc 2H51 a good long term investmentPrice Volatility Patterns & You’ll Regret Not Buying These Early - earlytimes.in
Ocugen (NASDAQ:OCGN) Hits New 52-Week HighHere's Why - MarketBeat
Published on: 2025-10-03 06:57:10 - newser.com
Regression analysis insights on Ocugen Inc. performanceTrade Volume Report & Low Risk High Reward Ideas - newser.com
How to recover losses in Ocugen Inc. stockGap Down & Entry and Exit Point Strategies - newser.com
Published on: 2025-10-03 02:54:41 - newser.com
Ocugen, Inc. to Present at NobleCon20 Emerging Growth Equity Conference - MSN
Ocugen Inc Azioni (OCGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):